NEW YORK (GenomeWeb News) – Qiagen reported after the close of the market on Monday that its first-quarter revenues rose 7 percent while its net income jumped around 22 percent year over year.

The Hilden, Germany-based molecular diagnostics and sample preparation technologies firm reported total sales of $220.9 million for the three months ended March 31, compared to sales of $207.1 million for the first quarter of 2008. Foreign currency translation had a negative 9 percent effect on the first-quarter results while acquisitions added 5 percent to its revenue growth.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.